跳至主要内容
临床试验/IRCT20220221054087N1
IRCT20220221054087N1尚未招募2 期

Investigate the effect of Crocin on Cognitive impairment, mental health,Oxidative Stress and inflammatory factors in Multiple Sclerosis patients

Kashan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Diagnosis of Multiple Sclerosis based on McDonald's criteria Age between 18 to 55 years
  • Testable Measurable Cognitive impairment (MACFIMS) attributed to Multiple Sclerosis
  • Testable Measurable mental health impairment including anxiety and depression (Beck) attributed to Multiple Sclerosis

排除标准

  • Breast feeding
  • History of Diabetes, heart failure, renal failure ,hepatic failure and psychological disorder
  • History of substance addiction
  • Sensitivity to crocin products
  • Clinical relapse of Multiple Sclerosis with in 30 days of screening
  • Changes in the treatment of Multiple Sclerosis within 30 days of screening
  • Existence of any underlying factor and disease that causes dementia and cognitive impairment

研究者

相似试验

Investigate the effect of Crocin in Multiple... | 临床试验